Berodual Respimat

ipratropium bromide and fenoterol hydrobromide · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Berodual Respimat, covering 2014-07-14 to 2014-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease